BioSyent Inc. (OTCMKTS:BIOYF – Get Free Report) saw a significant decline in short interest in the month of April. As of April 30th, there was short interest totaling 1,827 shares, a decline of 56.9% from the April 15th total of 4,242 shares. Based on an average trading volume of 2,431 shares, the short-interest ratio is presently 0.8 days.
BioSyent Stock Down 0.7%
Shares of BIOYF opened at $10.50 on Friday. BioSyent has a one year low of $7.63 and a one year high of $12.00. The business has a fifty day moving average of $10.85 and a 200 day moving average of $9.76.
About BioSyent
BioSyent Inc is a specialty biopharmaceutical company focused on developing, manufacturing and commercializing pharmaceutical products and medical devices. The company leverages expertise in regulatory affairs, clinical development and manufacturing to deliver a range of branded and generic therapies across multiple therapeutic areas, with particular emphasis on endocrine disorders, supportive care oncology and dermatology.
BioSyent operates a manufacturing facility in Canada that supports both its proprietary portfolio and contract development and manufacturing services (CDMO) for small-molecule products.
Featured Articles
- Five stocks we like better than BioSyent
- 3 Stocks to Own If Gas Prices Keep Rising
- 3 Crucial Aerospace Component Makers That Analysts Love
- Alphabet’s Googlebook Brings Gemini AI to PC Hardware
- Peloton Stock Gives Back Gains After Upbeat Earnings Report
Receive News & Ratings for BioSyent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSyent and related companies with MarketBeat.com's FREE daily email newsletter.
